2021 annual financial data
Arbutus Biopharma 2021 Operating cash flow margin
Arbutus Biopharma 2021 operating cash flow margin with verified reported values.
Direct answer
Operating cash flow margin was -614.6%.
Operating income was -73,522,000 USD and net income was -76,247,000 USD.
Operating cash flow was -67,532,000 USD.
Get free Arbutus Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 10,988,000 USD
- Operating income
- -73,522,000 USD
- Net income
- -76,247,000 USD
- Operating cash flow
- -67,532,000 USD